Options
Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial
Journal
Annals of the Rheumatic Diseases
Journal Volume
80
Journal Issue
8
Start Page
1014-1021
ISSN
0003-4967
Date Issued
2021-08
Author(s)
Tae-Hwan Kim
Mitsumasa Kishimoto
Naoki Ogusu
Haeyoun Jeong
Shigeto Kobayashi
Kurisu Tada
Mitsumasa Kishimoto
Kou Katayama
Atsuo Taniguchi
Yohei Seto
Mitsuhiro Morita
Kazuhiro Hatta
Tetsuya Tomita
Nobuo Negoro
Hitoshi Goto
Shigeyoshi Tsuji
Norikazu Murata
Kiyoshi Matsui
Masahiro Yamamura
Hiroaki Dobashi
Junichi Fukushi
Satoshi Ikemura
Akira Maeyama
Mitsuyo Kinjo
Yukitaka Ueki
Eishi Uechi
Tatsuya Atsumi
Hideto Kameda
Yoshinori Taniguchi
Sei Muraoka
Masanobu Oishi
Seung Jae Hong
Won Park
Shin Seok Lee
Chang Hee Suh
Seong Wook Kang
Tae-Hwan Kim
Jung Yoon Choe
Ji Hyeon Ju
Jin Kyun Park
Seung-Geun Lee
Yun Jong Lee
Sang-Heon Lee
Cheng Chung Wei
Tien Tsai Cheng
Wen Chan Tsai
Chung Ming Huang
Hsin Hua Chen
Der-Yuan Chen
Meng Yu Weng
Shue Fen Luo
Kun Hung Chen
Ling Jung Yen
Cheng Han Wu
Hsiang Cheng Chen
SDGs
Publisher
Elsevier BV
Type
journal-article